United States · FDA National Drug Code directory
FINACEA FOAM
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50222-303_f51a0452-513f-488f-b0f9-b723cf96bdf7
- Product NDC
- 50222-303
- Form
- AEROSOL, FOAM
- Composition / generic term
- azelaic acid
- Labeler
- LEO Pharma Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20181001
- Source listing expiry
- 20261231
Source-listed ingredients
- AZELAIC ACID — .15 g/g
These values do not establish equivalence or a dose recommendation.
Packages
- 1 CAN in 1 CARTON (50222-303-50) / 50 g in 1 CAN · 50222-303-50
- 1 CAN in 1 CARTON (50222-303-91) / 15 g in 1 CAN · 50222-303-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →